Recombinant Zoster Vaccine in Frail Individuals Recombinant Zoster Vaccine in Frail Individuals
This study evaluated the safety and efficacy of the two-dose adjuvanted recombinant zoster vaccine in frail individuals in a real-world setting.Journal of the American Geriatrics Society
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news
More News: Geriatrics | Health | Internal Medicine | Study | Vaccines | Varicella-Zoster Virus Vaccine